Planta Med 2001; 67(1): 89-91
DOI: 10.1055/s-2001-10630
Letter

© Georg Thieme Verlag Stuttgart · New York

In vitro Antiplasmodial Activity of 4-Phenylcoumarins from Exostema mexicanum

Inga Köhler1 , Kristina Jenett-Siems1,*, Frank P. Mockenhaupt2 , Karsten Siems3 , Jasmin Jakupovic3 , Julio C. González4 , Marco A. Hernández4 , Ricardo A. Ibarra4 , Walter G. Berendsohn5 , Ulrich Bienzle2 , Eckart Eich1
  • 1 Institut für Pharmazie (Pharmazeutische Biologie), Freie Universität Berlin, Berlin, Germany
  • 2 Institut für Tropenmedizin, Medizinische Fakultät Charité, Humboldt Universität zu Berlin, Berlin, Germany
  • 3 AnalytiCon AG, Potsdam, Germany
  • 4 ProBioTec S. A. de C. V., San Salvador, El Salvador
  • 5 Botanischer Garten und Botanisches Museum Berlin-Dahlem, Berlin, Germany
Weitere Informationen

Publikationsverlauf

February 25, 2000

June 24, 2000

Publikationsdatum:
31. Dezember 2001 (online)

Preview

Abstract

The stem bark of Exostema mexicanum (Rubiaceae) is used in Latin American folk medicine as a quinine substitute for malaria treatment. Bioassay-guided fractionation of lipophilic and hydrophilic extracts from the stem bark and branches yielded two previously undescribed 4-phenylcoumarins: 4′,8-dihydroxy-5,7-dimethoxy-4-phenylcoumarin (exomexin A) and 3′,4′-dihydroxy-5,7,8-trimethoxy-4-phenylcoumarin (exomexin B). Together with five known derivatives the in vitro activities against a chloroquine-sensitive strain (poW) and a chloroquine-resistant strain (Dd2) of Plasmodium falciparum have been evaluated. The most lipophilic compound, 4′,5,7,8-tetramethoxy-4-phenylcoumarin (O-methylexostemin) revealed the strongest antiplasmodial activity (IC50 values: 3.6 μg/ml [poW], 1.6 μg/ml [Dd2]).

References

Dr. Kristina Jenett-Siems

Institut für Pharmazie (Pharmazeutische Biologie)

Freie Universität Berlin

Königin-Luise-Str. 2 - 4

14195 Berlin

Germany

eMail: kjsiems@zedat.fu-berlin.de

Telefon: Tel: 030-83853720